Managing controversy through consultation: a qualitative study of communication and trust around MMR vaccination decisions.

BACKGROUND Controversy over the measles, mumps, and rubella (MMR) vaccine has reduced uptake, raising concerns of a future disease epidemic. AIMS To explore parents' accounts of decision making relating to the MMR vaccine controversy, identifying uptake determinants and education needs. DESIGN OF STUDY Qualitative interviews analysed using the 'framework' approach. SETTING Five general practices in the Leeds area, 2002-2003. METHOD Sixty-nine interviews conducted with parents of children aged between 4 and 5 years, and 12 interviews with primary care practitioners, managers and immunisation coordinators serving participating sites. Participants were interviewed one-to-one in a place of their choice. RESULTS The vaccination decision is primarily a function of parental assessments of the relative acceptability and likelihood of possible outcomes. For most parents the evidence of science and medicine plays little role in the decision. Although local general practitioners and health visitors are trusted information sources, the influence of primary care providers on the vaccination decision is limited by concerns over consultation legitimacy, discussion opportunity, and perceptions of financial and political partiality. Parents and practitioners identify a need for new approaches to support decisions and learning when faced with this and similar healthcare controversies. These include new collaborative approaches to information exchange designed to transform rather than supplant existing parent knowledge as part of an ongoing learning process. CONCLUSION The study identified new ways in which parents and practitioners need to be supported in order to increase understanding of medical science and secure more informed decisions in the face of health controversy.

[1]  J. Carlin,et al.  Vaccine preventable diseases and immunisations: a qualitative study of mothers? perceptions of severity, susceptibility, benefits and barriers , 1998, Australian and New Zealand Journal of Public Health.

[2]  N. Begg,et al.  Media dents confidence in MMR vaccine , 1998 .

[3]  M. Bartczak,et al.  Original Papers , 2009 .

[4]  A. Culyer,et al.  Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews. , 1998, Health technology assessment.

[5]  J. Schlesselman,et al.  A national survey to understand why physicians defer childhood immunizations. , 1997, Archives of pediatrics & adolescent medicine.

[6]  P. Impicciatore,et al.  Mothers as active partners in the prevention of childhood diseases: maternal factors related to immunization status of preschool children in Italy. , 2000, Preventive medicine.

[7]  I. Jones,et al.  Measles immunisation: results of a local programme to increase vaccine uptake. , 1985, British medical journal.

[8]  Richard Thomson,et al.  The importance of patient preferences in treatment decisions—challenges for doctors , 2003, BMJ : British Medical Journal.

[9]  D. Jewell MMR and the age of unreason. , 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.

[10]  John W. Glasser,et al.  Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.

[11]  L. Spencer,et al.  Qualitative data analysis for applied policy research , 2002 .

[12]  H. Stoddart,et al.  Parents' perspectives on the MMR immunisation: a focus group study. , 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.

[13]  E. Murphy,et al.  Qualitative research methods in health technology assessment: a review of the literature. , 1998, Health technology assessment.

[14]  J. Vernon Immunisation policy: from compliance to concordance? , 2003, The British journal of general practice : the journal of the Royal College of General Practitioners.

[15]  etc.,et al.  Inarticulate Science?: Perspectives on the Public Understanding of Science and Some Implications for Science Education , 1993 .

[16]  G. Schild,et al.  Clinical safety issues of measles, mumps and rubella vaccines. , 2000, Bulletin of the World Health Organization.

[17]  G. Elwyn,et al.  One hundred years ago: Should milk be boiled? , 2002, BMJ : British Medical Journal.

[18]  H. Bedford,et al.  MMR vaccine—worries are not justified , 2001, Archives of disease in childhood.

[19]  O. Heinonen,et al.  Total elimination of measles in Finland. , 1998, Annals of medicine.

[20]  H. Campbell,et al.  Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.